Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Wizz Air Holdings PLC (WIZZ.L): Analyst Ratings Point to Modest Upside Amid Volatile Market 16 January 2026
Victrex PLC (VCT.L) Stock Analysis: High Dividend Yield Amid Challenging Valuation Metrics 16 January 2026
VinaCapital Vietnam Opportunity (VOF.L) Stock Analysis: Exploring an 18% Potential Upside 16 January 2026
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Wizz Air Holdings PLC (WIZZ.L): Analyst Ratings Point to Modest Upside Amid Volatile Market 16 January 2026
Victrex PLC (VCT.L) Stock Analysis: High Dividend Yield Amid Challenging Valuation Metrics 16 January 2026
VinaCapital Vietnam Opportunity (VOF.L) Stock Analysis: Exploring an 18% Potential Upside 16 January 2026
Geron Corporation (GERN) Stock Analysis: Biotech Pioneer with a Potential Upside of 157.14% 26 December 2025
Arbutus Biopharma Corporation (ABUS) Stock Analysis: Unveiling a 19.95% Potential Upside in the Biotech Sector 26 December 2025
Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 68.79% Potential Upside for Investors 26 December 2025
Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 42.63% Potential Upside in the Biotech Sector 26 December 2025
Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Potential Upside of 183.41% and Strong Buy Ratings 26 December 2025
Fulgent Genetics (FLGT) Investor Outlook: Exploring 24.65% Potential Upside in the Diagnostics Sector 26 December 2025
CareDx, Inc. (CDNA) Stock Analysis: Exploring a 16.57% Potential Upside in the Healthcare Sector 26 December 2025
Kura Oncology, Inc. (KURA) Stock Analysis: Biotech Innovator with a 198% Upside Potential 26 December 2025
ArriVent BioPharma, Inc. (AVBP) Stock Analysis: A Biotech with an 80.50% Upside Potential 26 December 2025
Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Healthcare Innovator with 139% Potential Upside 26 December 2025
Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a Promising 26.73% Upside in the Biotech Sector 26 December 2025
AnaptysBio, Inc. (ANAB) Stock Analysis: 30% Upside Potential with Strong Analyst Support 26 December 2025
REGENXBIO Inc. (RGNX) Stock Analysis: Exploring the 110% Potential Upside and Strategic Growth in Gene Therapy 26 December 2025
Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Unpacking a Potential 82.5% Upside in Gene Therapy Innovation 26 December 2025
uniQure N.V. (QURE) Stock Analysis: Exploring a 120.75% Potential Upside in Gene Therapy Innovation 26 December 2025
Immatics N.V. (IMTX) Stock Analysis: Riding the Biotechnology Wave with an 80.81% Potential Upside 26 December 2025
Touchstone Exploration to accelerate exploration, development and production opportunities (VIDEO) 8 December 2022
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Wizz Air Holdings PLC (WIZZ.L): Analyst Ratings Point to Modest Upside Amid Volatile Market 16 January 2026
Victrex PLC (VCT.L) Stock Analysis: High Dividend Yield Amid Challenging Valuation Metrics 16 January 2026
VinaCapital Vietnam Opportunity (VOF.L) Stock Analysis: Exploring an 18% Potential Upside 16 January 2026
